Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease

Authors :: Rossato, P
Glantschnig, H
Canneva, F
Schuster, M
Coulibaly, S
Schrenk, G
Voelkel, D
Dockal, M
Plaimauer, B
Rottensteiner, H
Gritsch, H
Federti, E
Matte, A
DE FRANCESCHI, Lucia
Scheiflinger, F
Hoellriegl, W
Source :: Journal of Thrombosis and Haemostasis. 21:269-275
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Subjects :: mouse model
vaso-occlusive crisis
recombinant ADAMTS13
sickle cell disease
Hematology
ADAMTS13

Full Text Access

Tools